WCN26-8324 Epigenetic Regulatory Mechanisms and Therapeutic Potential of DNMT1 in Kidney Diseases

Read full text Summarise with VIRAT
Authors: Xiaofei Huang, Nan Zhu
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

DNA methyltransferase 1 (DNMT1), a key enzyme responsible for maintaining DNA methylation patterns, contributes to the progression of kidney diseases through epigenetic regulation of gene expression. Emerging evidence highlights aberrant DNMT1 expression in diabetic kidney disease (DKD), hepatitis B virus-associated glomerulonephritis (HBV-GN), acute kidney injury (AKI), chronic kidney disease (CKD), autosomal dominant polycystic kidney disease (ADPKD),and clear cell renal cell carcinoma (ccRCC).

Fields of Study & Subjects

Epigenetics and DNA Methylation Chronic Kidney Disease and Diabetes Renal Diseases and Glomerulopathies

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105406–105406
Publication date
25 March 2026
Language
EN